BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1213665)

  • 1. Prolongation of duration of action of 1-deamino-8-D-arginine vasopressin (DDAVP) by ineffective doses of clofibrate in diabetes insipidus.
    Radó JP; Marosi J
    Horm Metab Res; 1975 Nov; 7(6):527-8. PubMed ID: 1213665
    [No Abstract]   [Full Text] [Related]  

  • 2. Lengthening of the duration of action of DDAVP by "ineffective" doses of clofibrate in patients with pituitary diabetes insipidus.
    Radó JP; Marosi J
    Endokrinologie; 1976 Jun; 67(2):220-9. PubMed ID: 954691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Drug therapy of diabetes insipidus].
    Quist Paulsen A
    Tidsskr Nor Laegeforen; 1976 Aug; 96(23):1222-3. PubMed ID: 968848
    [No Abstract]   [Full Text] [Related]  

  • 4. Individual differences in the antidiuretic response induced by single doses of 1-deamino-8-D-arginine-vasopressin (DDAVP) in patients with pituitary diabetes insipidus.
    Radó JP; Marosi J; Borbély L; Takó J
    Int J Clin Pharmacol Biopharm; 1976 Dec; 14(4):259-65. PubMed ID: 1002361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1-deamino-8-D-arginine vasopressin in the treatment of central diabetes insipidus in childhood.
    Becker DJ; Foley TP
    J Pediatr; 1978 Jun; 92(6):1011-5. PubMed ID: 660339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical experience with DDAVP (1-deamino-8-D-arginine vasopressin), a new synthetic analog of vasopressin, in the treatment of childhood diabetes insipidus].
    Lebacq E; David L
    Pediatrie; 1975; 30(3):265-270. PubMed ID: 1178251
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of diabetes insipidus with 1-deamino-8-d-arginine vasopressin.
    Czakó L; Mezei G; László FA
    Acta Med Acad Sci Hung; 1975; 32(1):75-84. PubMed ID: 1233863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapy of central diabetes insipidus with a new synthetic preparation: DDAVP (1-deamino-8-D arginine vasopressin). Preliminary experience in 5 cases].
    Bernasconi S; Vanelli M; Giovannelli G
    Minerva Pediatr; 1975 Feb; 27(5):321-6. PubMed ID: 775282
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of diabetes insipidus with DDAVP.
    Kikugawa CA; Cortopassi RF; Ditmer DG; Okamoto WS
    Am J Hosp Pharm; 1977 Sep; 34(9):1013-7. PubMed ID: 906988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the diuretic action of glibenclamide by clofibrate, carbamazepine and 1-deamino-8-d-arginine-vasopressin (DDAVP) in patients with pituitary diabetes insipidus.
    Radó JP; Szende L; Marosi J; Juhos E; Sawinsky I; Takó J
    Acta Diabetol Lat; 1974; 11(3):179-97. PubMed ID: 4218049
    [No Abstract]   [Full Text] [Related]  

  • 11. DDAVP in the treatment of diabetes insipidus: a clinical study.
    Graham JJ; Wise PH; Harding PE
    Med J Aust; 1977 Jul; 2(4):113-6. PubMed ID: 895639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of diabetes insipidus with DDAVP, a synthetic analog of vasopressin].
    Kauli R; Laron Z
    Harefuah; 1975 Jul; 89(1):6-8. PubMed ID: 1158246
    [No Abstract]   [Full Text] [Related]  

  • 13. Desmopressin (DDAVP) in diabetes insipidus.
    Drug Ther Bull; 1976 Oct; 14(21):81-2. PubMed ID: 976094
    [No Abstract]   [Full Text] [Related]  

  • 14. DDAVP in the treatment of central diabetes insipidus.
    Robinson AG
    N Engl J Med; 1976 Mar; 294(10):507-11. PubMed ID: 1250255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasopressin analog DDAVP in the treatment of diabetes insipidus.
    Lee WP; Lippe BM; La Franchi SH; Kaplan SA
    Am J Dis Child; 1976 Feb; 130(2):166-9. PubMed ID: 766613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of vasopressin-sensitive diabetes insipidus in children with DDAVP].
    Gerards LJ; van Leeuwen EF; Donckerwolcke RA; Kuijten RH
    Ned Tijdschr Geneeskd; 1975 Aug; 119(33):1269-72. PubMed ID: 1165795
    [No Abstract]   [Full Text] [Related]  

  • 17. [Studies of a new synthetic vasopressin derivative (DDAVP) in man].
    Radó J; Marosi J; Szende L; Borbély L; Takó J; Fischer J
    Orv Hetil; 1976 Mar; 117(13):775-8. PubMed ID: 768869
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment with DDAVP in central diabetes insipidus. Review of our experience].
    Bernasconi S; Vanelli M; Volta C; Solli R; Cavagni G; Giovannelli G
    Minerva Pediatr; 1978 Jul; 30(13):1111-4. PubMed ID: 672852
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparative study of adiuretin-SD (DDAVP) and pitressin tannate in diabetes insipidus].
    László C; János J; Ferenc L
    Orv Hetil; 1977 Jul; 118(28):1648-50. PubMed ID: 876650
    [No Abstract]   [Full Text] [Related]  

  • 20. Shortened duration of action of 1-deamino-8-D-arginine vasopressin (DDAVP) in patients with diabetes insipidus requiring high doses of peroral antidiuretic drugs.
    Radó JP; Marosi J; Fischer J
    J Clin Pharmacol; 1976 Oct; 16(10 Pt 1):518-24. PubMed ID: 789414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.